[Preclinical study of Reamberin and Remaxol safety].
Savateeva-Liubimova TN, Lesiovskaia EE, Sivak KV, Stosman KI, Shevchuk MK, Dagaev SG, Savateev AV, Kovalenko AL, Petrov AIu, Sukhanov DS.
Savateeva-Liubimova TN, et al. Among authors: sivak kv.
Eksp Klin Farmakol. 2010 Nov;73(11):41-3.
Eksp Klin Farmakol. 2010.
PMID: 21254599
Russian.